| 1 |
34474172 | Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis. | 2022 Jan |
2 |
| 2 |
35115294 | Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. | 2022 Feb |
1 |
| 3 |
35156626 | Identifying physician-perceived barriers to a pragmatic treatment trial in rheumatoid arthritis. | 2022 Feb 14 |
3 |
| 4 |
35206926 | Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases. | 2022 Feb 7 |
1 |
| 5 |
35411376 | Antibody Response to SARS-CoV-2 mRNA Vaccines in Patients with Rheumatic Diseases in Japan: Interim Analysis of a Multicenter Cohort Study. | 2022 Apr 12 |
2 |
| 6 |
35464810 | Is there still a place for methotrexate in severe psoriatic arthritis? | 2022 |
1 |
| 7 |
33026092 | Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register. | 2021 Apr 6 |
1 |
| 8 |
33097960 | PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis. | 2021 Apr 6 |
1 |
| 9 |
33441299 | Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study. | 2021 Jan 13 |
1 |
| 10 |
33715177 | Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry. | 2021 May |
4 |
| 11 |
33745173 | Editorial: methotrexate in patients with Crohn's disease refractory to anti-TNF therapy-moving backwards yet forward? | 2021 Apr |
1 |
| 12 |
33822354 | Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs. | 2021 Jul |
1 |
| 13 |
34151447 | Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study. | 2021 Aug |
1 |
| 14 |
34223982 | Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate : A network meta-analysis. | 2021 Jul 5 |
3 |
| 15 |
34319853 | Folate-methotrexate loaded bovine serum albumin nanoparticles preparation: an in vitro drug targeting cytokines overwhelming expressed immune cells from rheumatoid arthritis patients. | 2021 Jul 28 |
2 |
| 16 |
34412031 | Correction: Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. | 2021 May |
1 |
| 17 |
34490293 | Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease. | 2021 |
2 |
| 18 |
34731780 | Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic. | 2021 Dec |
1 |
| 19 |
34775778 | Thalidomide may be an effective drug for Blau syndrome: a case report. | 2021 Nov 9 |
1 |
| 20 |
31691828 | The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients. | 2020 Jul 1 |
3 |
| 21 |
31758423 | Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients. | 2020 Mar |
2 |
| 22 |
31814481 | Successful cessation of tumor necrosis factor inhibitor treatment in rheumatoid arthritis patients and potential predictors for early flare: An observational study in routine clinical care. | 2020 Nov |
2 |
| 23 |
31998962 | Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register. | 2020 Sep 1 |
1 |
| 24 |
32147565 | Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA). | 2020 Jul |
1 |
| 25 |
32203525 | Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis. | 2020 |
1 |
| 26 |
32210391 | Does methotrexate improve TNF inhibitor drug survival in elderly patients with RA? | 2020 Jul |
1 |
| 27 |
32458964 | Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells. | 2020 Jun 26 |
1 |
| 28 |
32477604 | Lipophilic Prodrug of Methotrexate in the Membrane of Liposomes Promotes Their Uptake by Human Blood Phagocytes. | 2020 Jan-Mar |
1 |
| 29 |
32813925 | In silico evaluation of drugs used in treatment of oral lichen planus. | 2020 Oct |
1 |
| 30 |
32922407 | Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents. | 2020 |
9 |
| 31 |
29023282 | Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis. | 2019 May/Jun |
1 |
| 32 |
29752633 | Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. | 2019 Jan |
1 |
| 33 |
29754190 | Allergic and Immunologic Perspectives of Inflammatory Bowel Disease. | 2019 Oct |
1 |
| 34 |
30081197 | Methotrexate mechanism in treatment of rheumatoid arthritis. | 2019 May |
1 |
| 35 |
30560332 | Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease. | 2019 Jun |
3 |
| 36 |
30700574 | Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. | 2019 Jan 30 |
1 |
| 37 |
30888405 | Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases. | 2019 Aug 14 |
1 |
| 38 |
30913494 | Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation. | 2019 Jun |
1 |
| 39 |
31087133 | [Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs]. | 2019 Sep |
1 |
| 40 |
31101850 | Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients. | 2019 May 17 |
1 |
| 41 |
31311386 | Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis. | 2019 Sep |
4 |
| 42 |
31335881 | Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study. | 2019 |
1 |
| 43 |
31342661 | Machine Learning to Predict Anti-Tumor Necrosis Factor Drug Responses of Rheumatoid Arthritis Patients by Integrating Clinical and Genetic Markers. | 2019 Dec |
1 |
| 44 |
31388915 | Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis. | 2019 Oct |
1 |
| 45 |
31443722 | Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. | 2019 Aug 23 |
1 |
| 46 |
32254955 | Targeted hexagonal Pd nanosheet combination therapy for rheumatoid arthritis via the photothermal controlled release of MTX. | 2019 Jan 7 |
1 |
| 47 |
32476962 | Methotrexate treatment efficacy in sarcoidosis might be related to TNF-α polymorphism: real life preliminary study. | 2019 |
1 |
| 48 |
27881030 | The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study. | 2018 Feb |
1 |
| 49 |
29314738 | Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors. | 2018 Mar |
1 |
| 50 |
29335345 | S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. | 2018 Apr |
2 |